Skip to content
DraconiticResearch
Search Sources API
201,642 studies31 sourcesUpdated 55 min ago
Peer-reviewedLicence not statedPsychopharmacology Bulletin

Genetic Polymorphisms and Hemostatic-Inflammatory Biomarkers in Schizophrenia Patients Receiving Antipsychotic Treatment

Related

  1. Hepato-Immune Crosstalk Underlies Antipsychotic-Associated Metabolic Dysregulation in Schizophrenia: Quercetin as a Therapeutic Candidate for High-Inflammatory Subtypes.
    Yi Yang, Bin Liu, Zhicheng Cao +10
    MetabolitesPeer-reviewedCC BYFull textPsychiatry & mental healthEurope PMC
  2. The LAI–Oral Antipsychotic Efficacy–Effectiveness Paradox in Schizophrenia
    Kaloyan Stoychev, Sara Begum, Sheraz Nazar
    Medicina (Kaunas, Lithuania)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Baseline severity of positive and negative symptoms predicts relapse in opposing directions among placebo-treated schizophrenia patients: analysis of five placebo-controlled, antipsychotic withdrawal, relapse-prevention trials
    J. Rabinowitz, M. Davidson, C. U. Correll +5
    medRxivPreprintCC BY-NDFull textPsychiatry & mental healthmedRxiv
  4. Metabolic syndrome in stable long-term antipsychotic monotherapy and polypharmacy among patients with schizophrenia: a real-world comparative study.
    Haluk Usta, Didem Beşikci Keleş
    Frontiers in psychiatryPeer-reviewedCC BYFull textPsychiatry & mental healthEurope PMCCrossref
  5. Sex differences in QTc prolongation and electrocardiographic changes before and after antipsychotic treatment of schizophrenia
    Xinwang Song, Fangcheng Fan, Jiaquan Liang
    Frontiers in PsychiatryPeer-reviewedCC BY 4.0Full textPsychiatry & mental healthCrossrefEurope PMCPMC
BibTeX
@article{hasni2026genetic,
  title = {{Genetic Polymorphisms and Hemostatic-Inflammatory Biomarkers in Schizophrenia Patients Receiving Antipsychotic Treatment}},
  author = {Dita Hasni and Debie Anggraini and Mutiara Anissa and Lieka Nugrahi Jaslindo},
  journal = {Psychopharmacology Bulletin},
  year = {2026},
  month = oct,
  doi = {10.64719/pb.21624},
  url = {https://doi.org/10.64719/pb.21624},
}
RIS
TY  - JOUR
TI  - Genetic Polymorphisms and Hemostatic-Inflammatory Biomarkers in Schizophrenia Patients Receiving Antipsychotic Treatment
AU  - Dita Hasni
AU  - Debie Anggraini
AU  - Mutiara Anissa
AU  - Lieka Nugrahi Jaslindo
PY  - 2026
DA  - 2026/10/30
JO  - Psychopharmacology Bulletin
DO  - 10.64719/pb.21624
UR  - https://doi.org/10.64719/pb.21624
SN  - 0048-5764
SN  - 2472-2448
ER  -